The Carlyle Group has committed JPY 7bn (USD 52.2m) to CureApp, a Japan-based developer of software for use in the treatment of medical conditions, as part of the company’s Series G round.
CureApp has now raised approximately JPY 13.4bn to date. Beyond Next Ventures was its first backer in 2015. AVCJ Research has records of four subsequent rounds featuring the likes of SBI Investment, Chibagin...
Asian private equity has moved on from chasing momentum plays, with GPs increasingly pursuing opportunities where they have domain expertise and know they can add value, the AVCJ Private Equity & Venture Forum heard.
An emerging technology giant has imploded. Regulations are set to tighten. Investors hit pause but remain confident about the long-term outlook. Business as usual in crypto
Patrick Reid, a UK-based managing director for alternatives distribution management at Morgan Stanley, plots the future of themes around secondaries, longer holds, and hybrid approaches to PE
LionRock Capital is exiting Clarks to its majority partner, Li Ning-owned and Hong Kong-listed Viva China, having helped the struggling British shoe brand survive the pandemic